Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors
- PMID: 8787546
- DOI: 10.1016/0006-2952(96)00038-x
Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors
Abstract
The efficiency of both anionic and cationic liposomes as vectors for in vivo human alpha1-antitrypsin (AAT) gene transfer was studied in mice with and without an associated partial hepatectomy. The pTG7101 plasmid, containing the full-length human AAT gene, was encapsulated in small liposomes bearing 10% of negatively (phosphatidylserine, PS) or positively (DOTAP) charged lipids. The results indicated that the DNA/lipid ratio was increased in cationic liposomes by inclusion of monosialoganglioside-GM1. The expression of human protein after in vivo gene transfer was quantified in mouse plasma by an ELISA procedure, and revealed that both anionic and cationic liposomes mediated the presence of human protein in mouse plasma for 2-3 weeks. This effect was prolonged (>5 months) when a partial hepatectomy was performed after treatment. In addition, it was observed that the efficacy of liposome-mediated gene transfer was more limited when the plasmid was externally associated to cationic liposomes.
Similar articles
-
Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vector.Biochem Pharmacol. 1997 Jul 1;54(1):9-13. doi: 10.1016/s0006-2952(97)00872-1. Biochem Pharmacol. 1997. PMID: 9296345 Review.
-
Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.J Mol Med (Berl). 2001 May;79(4):205-12. doi: 10.1007/s001090000185. J Mol Med (Berl). 2001. PMID: 11409712
-
Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes.Biochem Biophys Res Commun. 1994 Nov 15;204(3):1023-30. doi: 10.1006/bbrc.1994.2565. Biochem Biophys Res Commun. 1994. PMID: 7980573
-
Human alpha 1-antitrypsin gene transfer to in vivo mouse hepatocytes.Hum Gene Ther. 1996 Mar 1;7(4):531-6. doi: 10.1089/hum.1996.7.4-531. Hum Gene Ther. 1996. PMID: 8800748
-
Gene therapy progress and prospects: alpha-1 antitrypsin.Gene Ther. 2003 Jan;10(2):95-9. doi: 10.1038/sj.gt.3301947. Gene Ther. 2003. PMID: 12571637 Review.
Cited by
-
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.Gut. 2002 Jan;50(1):130-5. doi: 10.1136/gut.50.1.130. Gut. 2002. PMID: 11772981 Free PMC article. Review.
-
5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.Mol Ther. 2017 Jun 7;25(6):1387-1394. doi: 10.1016/j.ymthe.2017.03.029. Epub 2017 Apr 10. Mol Ther. 2017. PMID: 28408179 Free PMC article.
-
In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA.Biomater Sci. 2022 Dec 6;10(24):6968-6979. doi: 10.1039/d2bm01289h. Biomater Sci. 2022. PMID: 36222485 Free PMC article.
-
In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice.Pharmaceutics. 2020 Aug 21;12(9):793. doi: 10.3390/pharmaceutics12090793. Pharmaceutics. 2020. PMID: 32825773 Free PMC article.
-
Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Ann Am Thorac Soc. 2016 Aug;13 Suppl 4(Suppl 4):S352-69. doi: 10.1513/AnnalsATS.201506-344KV. Ann Am Thorac Soc. 2016. PMID: 27564673 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous